A carregar...

Cabozantinib for progressive metastatic medullary thyroid cancer: a review

Medullary thyroid cancer is uncommon and patients typically present with advanced disease. Treatment options for patients with progressive, metastatic medullary thyroid cancer had been limited until recently. Tyrosine kinase inhibitors have garnered increasing interest in this subset of patients. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Colombo, Joshua R, Wein, Richard O
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4043815/
https://ncbi.nlm.nih.gov/pubmed/24920914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S46041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!